Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Women With Uterine Myoma”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Not applicableStudy completedNCT03533907
What this trial is testing

Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.

Who this might be right for
Myoma;UterusInfertility, Female
Istituto Clinico Humanitas 20
Large-scale testing (Phase 3)Looking for participantsNCT05862272
What this trial is testing

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Who this might be right for
Uterine FibroidsEndometriosis
Sumitomo Pharma Switzerland GmbH 1,000
Post-approval studies (Phase 4)Study completedNCT00628901
What this trial is testing

A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)

Who this might be right for
LeiomyomaUterine FibroidsUterine Neoplasms+2 more
Boston Scientific Corporation 60
Large-scale testing (Phase 3)Study completedNCT02147197
What this trial is testing

The Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Who this might be right for
LeiomyomaUterine Hemorrhage
Allergan 157
Testing effectiveness (Phase 2)Ended earlyNCT02811159
What this trial is testing

An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 20
Large-scale testing (Phase 3)Study completedNCT02654054
What this trial is testing

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Who this might be right for
Uterine FibroidsHeavy Menstrual Bleeding
AbbVie 413
Not applicableEnded earlyNCT00001850
What this trial is testing

Evaluation of Women With Endocrine and Reproductive-Related Conditions

Who this might be right for
Endocrine DiseaseInfertilityLeiomyoma+2 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 833
Not applicableUnknownNCT06208891
What this trial is testing

Clinical Outcomes of Robotic Myomectomy

Who this might be right for
Women With Uterine Myoma
Far Eastern Memorial Hospital 400
Not applicableEnded earlyNCT00730886
What this trial is testing

ExAblate Treatment of Uterine Fibroids for Fertility Enhancement

Who this might be right for
Uterine Fibroids, With Unexplained Infertility
InSightec 2
Not applicableStudy completedNCT02123069
What this trial is testing

Vascular Function and Uterine Fibroids

Who this might be right for
Leiomyoma
Mayo Clinic 28
Not applicableLooking for participantsNCT07480785
What this trial is testing

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Who this might be right for
Uterine Fibroids (Leiomyoma)Ovarian TumorsGallstones
Zhejiang University 780
Not applicableStudy completedNCT04030182
What this trial is testing

Vitamin D Deficit in Women With Uterine Fibroids

Who this might be right for
LeiomyomaVitamin D DeficiencyFibroid Uterus
Instituto Mexicano del Seguro Social 127
Not applicableUnknownNCT01635452
What this trial is testing

A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids

Who this might be right for
Uterine Fibroids
PregLem SA 1,500
Not applicableStudy completedNCT02472184
What this trial is testing

Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy

Who this might be right for
Uterine FibroidsVaginal Bleeding
University of South Florida 78
Large-scale testing (Phase 3)Study completedNCT03070899
What this trial is testing

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Who this might be right for
Uterine FibroidsHeavy Menstrual Bleeding
ObsEva SA 526
Early research (Phase 1)WithdrawnNCT03156127
What this trial is testing

Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

Who this might be right for
Uterine Myoma
Boryung Pharmaceutical Co., Ltd
Large-scale testing (Phase 3)Ended earlyNCT00702702
What this trial is testing

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

Who this might be right for
Uterine FibroidsAnemia
Repros Therapeutics Inc. 56
Large-scale testing (Phase 3)Study completedNCT02691494
What this trial is testing

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)

Who this might be right for
Uterine FibroidsHeavy Menstrual Bleeding
AbbVie 378
Not applicableStudy completedNCT03328260
What this trial is testing

High Intensity Focused Ultrasound in Uterine Myoma

Who this might be right for
Uterine Leiomyoma
Seoul National University Hospital 34
Testing effectiveness (Phase 2)Study completedNCT01069094
What this trial is testing

Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Who this might be right for
Uterine Leiomyomata
Repros Therapeutics Inc. 29
Next Page